SEC Form 4 · accession 0000874015-17-000031
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Patrick R. O'Neil
Officer — SVP, Legal & General Counsel
Period of report
May 1, 2017
Accepted (ET)
May 3, 2017 · 6:01 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | May 1, 2017 | S | 150 | $48.75 | D | 10,299 | D | |
| Common StockF2 | May 1, 2017 | M | 500 | $10.82 | A | 10,799 | D | |
| Common StockF2 | May 1, 2017 | S | 500 | $48.75 | D | 10,299 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy) | $10.82 | May 1, 2017 | M | 500 | D | Jan 2, 2017 | Jan 1, 2020 | Common Stock | 500 | 1,770 | D |
Explanation of responses
- F1The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 1/6/2017.
- F2Acquired as a result of exercising a stock option pursuant to Rule 10b5-1 Trading Plan. The purchase and sale reported on this Form 4 was effective pursuant to Rule 10b5-1 Trading Plan adopted by the reporting person on 1/6/2017.